[1]Patent:US2004/220194,2004,A1.Locationinpatent:Page18
100607-15-6
26583-55-1
886851-37-2
221915-84-0
836-59-9
915920-44-4
934240-31-0 | (2S,5R)-5-(4-((2-Fluorobenzyl)oxy)phenyl)pyrrolidine-2-carboxamide hydrochloride | AA00397I | MFCD28900694
42065-10-1 | 2-Chloro-5,6,8-trimethoxyquinoline | AA0039B4 | MFCD30293171
194865-89-9 | 4-(Tributylstannyl)pyridazine | AA0039EO | MFCD07787369
1374640-70-6 | Co-1686 | AA0039ID | MFCD26793864
87932-50-1 | 2-Chloro-3,4-dihydroxybenzoic acid | AA0039LF | MFCD20640292
15251-14-6 | Spiro[isobenzofuran-1(3H),9′-[9H]xanthen]-3-one, 4,5,6,7-tetrachloro-3′,6′-dihydroxy-2′,4′,5′,7′-tetraiodo-, labeled with iodine-131, sodium salt (1:2) | AA01X38N | MFCD00151169
78587-05-0 | rel-(4R,5R)-5-(4-Chlorophenyl)-N-cyclohexyl-4-methyl-2-oxo-3-thiazolidinecarboxamide | AA0039RS | MFCD17012610
3484-10-4 | 2-Methyl-4-nitroindole | AA0039VK | MFCD09028445
64163-10-6 | Pyrazine, 2,5-dibromo-3-phenyl- | AA0039ZD | MFCD30742908
811803-05-1 | Apatinib | AA003A34 | MFCD21648511